The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36

M. L. Febbraio, E. Guy, C. Coburn, F. F. Knapp, A. L. Beets, N. A. Abumrad, R. L. Silverstein

Research output: Contribution to journalReview articlepeer-review

71 Scopus citations


Fatty acid translocase (FAT)/CD36 has been associated with diverse normal and pathologic processes. These include scavenger receptor functions (uptake of apoptotic cells and modified lipid), lipid metabolism and fatty acid transport, adhesion, angiogenesis, modulation of inflammation, transforming growth factor-β activation, atherosclerosis, diabetes and cardiomyopathy. Although CD36 was identified more than 25 years ago, it is only with the advent of recent genetic technology that in vivo evidence has emerged for its physiologic and pathologic relevance. As these in vivo studies are expanded, we will gain further insight into the mechanism(s) by which CD36 transmits a cellular signal, and this will allow the design of specific therapeutics that impact on a particular function of CD36.

Original languageEnglish
Pages (from-to)193-197
Number of pages5
JournalMolecular and Cellular Biochemistry
Issue number1-2
StatePublished - Oct 2002


  • CD36
  • CD36 null
  • Fatty acid translocase
  • Fatty acid uptake


Dive into the research topics of 'The impact of overexpression and deficiency of fatty acid translocase (FAT)/CD36'. Together they form a unique fingerprint.

Cite this